JPMorgan analysts reiterated their positive stance on U.K. domestic banks, citing resilient returns, solid balance sheet ...

President Trump’s aim to slash U.S. prescription drug prices by 50% is unlikely to materialize, according to analysts at ...

The European Central Bank cut interest rates by 25 basis points on Thursday but signalled that further easing is unlikely ...

Investing.com -- Jefferies upgraded Southern Company (NYSE: SO) to Buy from Hold, citing stronger-than-expected long-term ...

Tesla (NASDAQ: TSLA) shares fell 7% following President Donald Trump’s public criticism of the company and its CEO, Elon Musk ...

Huawei’s new AI compute system, CloudMatrix 384, attempts to compensate for individual chip performance by linking as many as ...

Mizuho upgraded Visa Inc (NYSE: V) to Outperform from Neutral and raised its price target to $425 from $359, saying the shift ...

While specific details of the trade agreement remain sparse, Trump indicated that high-level follow-up meetings are imminent.

Securities said the Bank of Canada’s decision to hold its policy rate at 2.75% reflects a wait-and-see approach amid ...

HSBC upgraded Dr Reddy’s Laboratories to Buy from Hold and raised its target price to INR 1445, citing expectations that ...

BofA Global Research reiterated its bearish stance on the U.S. dollar in a note Thursday, even as it acknowledged that the ...

Investing.com -- Apple’s attempt to pause a lower court ruling that forces it to allow third-party payment links in its App ...